Accurant Biotech

Accurant Biotech is a privately held, revenue-generating CRO headquartered in San Diego, California, with significant operations in Princeton, New Jersey, and multiple locations in China. The company offers an integrated suite of development services, from bioanalytical testing and CMC to regulatory support, primarily for complex biologic modalities. Its business model is based on providing outsourced R&D services to pharmaceutical and biotech companies, leveraging its FDA-audited facilities and dual US-China footprint to serve a global clientele.

Integrated CRO service platform offering GLP bioanalysis (LBA, cell-based assays, flow cytometry, IHC, PCR, NGS, LC/MS), CMC testing (impurities, potency, structural analysis, glycosylation), clinical trial support, and regulatory consulting for biologics, oligonucleotides, and cell/gene therapies.

Accurant competes in a fragmented but crowded CRO market against giants like IQVIA, LabCorp, and PPD, as well as many specialized biologics CROs. Its differentiation hinges on deep expertise in complex modalities, a collaborative partnership model, and its strategic bridge between US and Chinese drug development ecosystems.